New interest to the lipid disturbances in CF has emerged since the modulators of the CFTR, from Ivacaftor to the latest triple combination ETI, have been shown to interfere with the lipid metabolism, especially with phosphatidylcholine (PC) and ceramides, both in humans39,40,41 and in CF cell cultures.41 Here, CFTR is linked to cystic fibrosis.